A business in context

KYMR research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-04 · 0001193125-26-383874

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-333849

  3. 8-K · Current report

    Report date 2026-08-05 · 0001193125-26-333834 · Items 2.02,9.01

  4. 4 · Ownership change

    Report date 2026-07-27 · 0001193125-26-318408

  5. 8-K · Current report

    Report date 2026-07-27 · 0001193125-26-318078 · Items 5.02,7.01,9.01

  6. 4 · Ownership change

    Report date 2026-07-07 · 0001193125-26-297817

  7. 4/A · Ownership change

    Report date 2026-06-26 · 0001451612-26-000022

  8. 4 · Ownership change

    Report date 2026-06-30 · 0001193125-26-295090

  9. 4 · Ownership change

    Report date 2026-07-01 · 0001193125-26-295089

  10. 4 · Ownership change

    Report date 2026-07-01 · 0001193125-26-295088

  11. 4 · Ownership change

    Report date 2026-06-26 · 0001451612-26-000020

  12. 8-K · Current report

    Report date 2026-06-25 · 0001193125-26-281817 · Items 7.01,8.01,9.01

  13. 8-K · Current report

    Report date 2026-06-24 · 0001193125-26-281051 · Items 5.07

  14. 8-K · Current report

    Report date 2026-06-05 · 0001193125-26-261698 · Items 5.02

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-193967

  16. 8-K · Current report

    Report date 2026-04-30 · 0001193125-26-193957 · Items 2.02,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-06-24 · 0001193125-26-191495

  18. 8-K · Current report

    Report date 2026-03-25 · 0001193125-26-129170 · Items 5.03,9.01

  19. 8-K · Current report

    Report date 2026-02-26 · 0001193125-26-073561 · Items 1.01,1.02,8.01,9.01

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-073395

  21. 8-K · Current report

    Report date 2026-02-26 · 0001193125-26-073386 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2026-01-13 · 0001193125-26-011104 · Items 2.02,7.01,9.01

  23. 8-K · Current report

    Report date 2025-12-08 · 0001193125-25-314422 · Items 1.01,8.01,9.01

  24. 8-K · Current report

    Report date 2025-12-08 · 0001193125-25-310670 · Items 7.01,9.01

  25. 8-K · Current report

    Report date 2025-12-08 · 0001193125-25-310572 · Items 7.01,8.01,9.01

  26. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-263550

  27. 8-K · Current report

    Report date 2025-11-04 · 0001193125-25-263540 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-08-27 · 0001193125-25-194481 · Items 5.02,7.01,9.01

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-106229

  30. 8-K · Current report

    Report date 2025-08-11 · 0000950170-25-106227 · Items 2.02,9.01

  31. 8-K · Current report

    Report date 2025-06-25 · 0001193125-25-151393 · Items 1.01,8.01,9.01

  32. 8-K · Current report

    Report date 2025-06-25 · 0001193125-25-151345 · Items 5.07

  33. 8-K · Current report

    Report date 2025-06-25 · 0001193125-25-146135 · Items 7.01,8.01,9.01

  34. 8-K · Current report

    Report date 2025-06-25 · 0001193125-25-146134 · Items 7.01,8.01,9.01

  35. 8-K · Current report

    Report date 2025-06-02 · 0001193125-25-132838 · Items 7.01,9.01

  36. 8-K · Current report

    Report date 2025-06-02 · 0001193125-25-132760 · Items 7.01,8.01,9.01

  37. 8-K · Current report

    Report date 2025-05-09 · 0001193125-25-116443 · Items 2.02,7.01,9.01

  38. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-067498

  39. DEF 14A · Proxy statement

    Report date 2025-06-25 · 0001193125-25-103767

  40. 8-K · Current report

    Report date 2025-03-03 · 0001193125-25-044151 · Items 5.02

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 162 transaction rows162SGrant / award: 10 transaction rows10AExercise / conversion: 44 transaction rows44MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

216 matching transaction rows. Showing 101–150.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-24
2026-06-25
Albers Jeffrey W.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
6068.00.0
2026-06-24
2026-06-25
Sandor VictorA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
6068.00.0
2026-06-24
2026-06-25
Esposito PamelaA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
6068.00.0
2026-06-24
2026-06-25
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPA · Grant / award
Acquired
Non-Qualified Stock Option (right to buy)
Derivative security
6068.00.0
2026-06-24
2026-06-25
667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPA · Grant / award
Acquired
Non-Qualified Stock Option (right to buy)
Derivative security
6068.00.0
2026-06-24
2026-06-25
BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK NA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
6068.00.0
2026-06-23
2026-06-25
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1235.099.98
2026-06-23
2026-06-25
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock173.099.98
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1341.0104.38
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2560.0103.42
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock18313.0103.42
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock9584.0104.38
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock14921.092.14
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2035.094.48
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock11783.095.12
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock20903.096.24
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock16084.097.68
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock25976.098.58
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock52442.099.57
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock56348.0100.17
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock6597.0101.61
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8990.0102.48
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2179.092.14
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock286.094.48
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1648.095.12
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2919.096.24
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2247.097.68
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3603.098.58
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock7319.099.57
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock7879.0100.17
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock918.0101.61
2026-06-22
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1253.0102.48
2026-06-22
2026-06-22
Goodman NoahM · Exercise / conversion
Acquired
Common Stock2500.021.05
2026-06-22
2026-06-22
Goodman NoahS · Sale
Disposed
Common Stock2500.099.0
2026-06-22
2026-06-22
Goodman NoahM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
2500.00.0
2026-06-18
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5672.092.16
2026-06-18
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock32359.091.85
2026-06-18
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock4526.091.85
2026-06-18
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock793.092.16
2026-06-18
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8809.090.48
2026-06-18
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock62897.090.48
2026-06-17
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock12902.090.38
2026-06-17
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock92169.090.38
2026-06-17
2026-06-22
Booth Bruce
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock11741.089.98
2026-06-17
2026-06-22
Booth Bruce
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock11741.020.0
2026-06-17
2026-06-22
Booth Bruce
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
11741.00.0
2026-06-02
2026-06-03
Jacobs Bruce N.M · Exercise / conversion
Acquired
Common Stock12653.02.08
2026-06-02
2026-06-03
Jacobs Bruce N.M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
12653.00.0
2026-05-27
2026-05-27
Chadwick Jeremy GS · Sale
Disposed
Common Stock600.082.08
2026-05-27
2026-05-27
Chadwick Jeremy GS · Sale
Disposed
Common Stock3679.081.5

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001815442Kymera Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Kymera Therapeutics · alias · wikidata
  • Kymera Therapeutics, Inc. · former SEC name · 2020-06-22 to 2026-09-04
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$47.07M$50.11M
2023-12-31$78.59M$86.12M
2022-12-31$46.83M$53.42M
2021-12-31$72.83M$89.74M
2020-12-31$34.03M$43.91M
2019-12-31$2.93M$3.83M

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗